SEARCH

SEARCH BY CITATION

References

  • 1
    Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2011 update Circulation. 2011;123:e18e209.
  • 2
    Centers for Disease Control and Prevention. Vital signs: prevalence, treatment, and control of hypertension – United States, 1999–2002 and 2005–2008. MMWR Morb Mortal Wkly Rep. 2011;60:103108.
  • 3
    Huffman MD, Capewell S, Ning H, et al. Cardiovascular health behavior and health factor changes (1988–2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation. 2012;125:25952602.
  • 4
    Chen JM, Geran BS, Perez MI, Wright JM. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension. Cochrane Database Syst Rev. 2010;(1):CD007185.
  • 5
    Diao D, Wright JM, Cundiff DK, Gueyffier F. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev. 2012;(8):CD006742.
  • 6
    Warren-Findlow J, Seymour RB. Prevalence rates of hypertension self-care activities among African Americans. J Natl Med Assoc. 2011;103:503512.
  • 7
    Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med. 2007;120:2632.
  • 8
    Adams AS, Uratsu C, Dyer W, et al. Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Inter Med. 2013;173:5461.
  • 9
    Marshall IJ, Wolfe CD, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012;345:e3953.
  • 10
    Wright JM, Musini VM. First line drugs for hypertension (Review). Cochrane Database Syst Rev. 2009;(3):CD001841.
  • 11
    Pittman DG, Tao Z, Chen W, Stettin GD. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am J Manag Care. 2010;16:568576.
  • 12
    Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:11051187.
  • 13
    Bavikati VV, Sperling LS, Salmon RD, et al. Effect of comprehensive therapeutic lifestyle changes on prehypertension. Am J Cardiol. 2008;102:16771680.
  • 14
    Weir MR, Maibach EW, Bakris GL, et al. Implications of a health lifestyle and medication analysis for improving hypertension control. Arch Intern Med. 2000;160:481490.
  • 15
    Gohar F, Greenfield SM, Beevers DG, et al. Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med. 2008;8:4
  • 16
    Ross Middleton KM, Patidar SM, Perri MG. The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev. 2012;13:509517.
  • 17
    Folsom AR, Parker ED, Harnack LJ. Degree of concordance with DASH diet guidelines and incidence of hypertension and fatal cardiovascular disease. Am J Hypertens. 2007;20:225232.
  • 18
    Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:12061252.
  • 19
    Harsha DW, Bray GA. Weight loss and blood pressure control (Pro). Hypertension. 2008;51:14201425.
  • 20
    Centers for Disease Control and Prevention (CDC). Prevalence of actions to control high blood pressure – 20 states, 2005. MMWR Morb Mortal Wkly Rep. 2007;56:420423.
  • 21
    Chen EH, Bodenheimer T. Improving population health through team-based panel management: comment on “electronic medical record reminders and panel management to improve primary care of elderly patients.” Arch Intern Med. 2011;171:15581559.
  • 22
    Loo TS, Davis RB, Lipsitz LA, et al. ELectronic medical record reminders and panel management to improve primary care of elderly patients. Arch Intern Med. 2011;171:15521558.
  • 23
    DeVellis RF. Scale Development: Theory and Applications. 2nd ed. Thousand Oaks, CA: Sage Publications; 2003.
  • 24
    National Institute on Alcohol Abuse and Alcoholism. The Physician's Guide to Helping Patients with Alcohol Problems. Washington, DC: NIH. Report No.: 95-3769.
  • 25
    U.S. Department of Health and Human Services. Your Guide to Lowering Your Blood Pressure With DASH. In. Bethesda, MD: National Institutes of Health; 2006.
  • 26
    Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12:239245.
  • 27
    Daugherty SL, Powers JD, Magid DJ, et al. The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension/novelty and significance. Hypertension. 2012;60:303309.
  • 28
    Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105116.
  • 29
    Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878884.
  • 30
    Appel LJ, Angell SY, Cobb LK, et al. Population-wide sodium reduction: the bumpy road from evidence to policy. Ann Epidemiol. 2012;22:417425.
  • 31
    Cohen HW, Hailpern SM, Alderman MH. Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). J Gen Intern Med. 2008;23:12971302.
  • 32
    Stolarz-Skrzypek K, Kuznetsova T, Thijs L, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011;305:17771785.
  • 33
    O'Donnell MJ, Yusuf S, Mente A, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011;306:22292238.
  • 34
    Yang Q, Liu T, Kuklina EV, et al. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2011;171:11831191.
  • 35
    Whitt-Glover MC, Hunter JC, Foy CG, et al. Translating the Dietary Approaches to Stop Hypertension (DASH) diet for use in underresourced, urban African American communities, 2010. Prev Chronic Dis. 2013;10:E06.
  • 36
    Ando K, Fujita T. Pathophysiology of salt sensitivity hypertension. Ann Med. 2012;44:S119S126.
  • 37
    Sanders PW. Dietary salt intake, salt sensitivity, and cardiovascular health. Hypertension. 2009;53:442445.
  • 38
    Kim MK, Lopetcharat K, Gerard PD, Drake MA. Consumer awareness of salt and sodium reduction and sodium labeling. J Food Sci. 2012;77:S307S313.